Semaglutide & Ketamine: Ozempic, Wegovy, Rybelsus Compatibility
Ozempic (Semaglutide) (also: Wegovy, Rybelsus) — GLP-1 receptor agonist (weight loss / type 2 diabetes)
Verdict at Tovani Health
Fully compatible; no meaningful interaction with KAP.
Semaglutide and ketamine have no clinically significant interaction. Whether you take it as Wegovy for chronic weight management, Ozempic by injection for type 2 diabetes, or Rybelsus as the oral tablet, KAP proceeds without medication changes. The two drug classes act on entirely separate systems — semaglutide at peripheral GLP-1 receptors, ketamine at central NMDA glutamate receptors — so there's no pharmacokinetic overlap, no shared metabolism, and no additive CNS or cardiovascular effect to plan around. The practical considerations are GI-side, not interaction-side: GLP-1 nausea and slowed gastric emptying can compound with session-day nerves if not anticipated. We coordinate session timing around dose-escalation windows when nausea is highest, and we'll pre-medicate with ondansetron for patients prone to motion-sensitive nausea.
If you take Ozempic regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Ozempic interacts with ketamine
Semaglutide agonizes the GLP-1 receptor — primarily on pancreatic beta cells (insulin secretion), the gut (slowed gastric emptying, satiety signaling), and CNS regions involved in appetite regulation. None of these pathways overlap with ketamine's mechanism (NMDA receptor antagonism + downstream BDNF/mTOR signaling). No CYP450 metabolism shared. No additive QT, blood-pressure, or sedation effects.
What we do at intake
Continue your normal dosing schedule. We do want to know: how long you've been on it, your current dose, your last dose-escalation date, and whether GI side effects are an issue for you. If your dose was increased in the last 10-14 days, we may delay the first session to let nausea plateau. Many of our patients are on semaglutide — this is a routine, well-understood combination.
Bottom line
Semaglutide and ketamine have no clinically significant interaction. Whether you take it as Wegovy for chronic weight management, Ozempic by injection for type 2 diabetes, or Rybelsus as the oral tablet, KAP proceeds without medication changes. The two drug classes act on entirely separate systems — semaglutide at peripheral GLP-1 receptors, ketamine at central NMDA glutamate receptors — so there's no pharmacokinetic overlap, no shared metabolism, and no additive CNS or cardiovascular effect to plan around. The practical considerations are GI-side, not interaction-side: GLP-1 nausea and slowed gastric emptying can compound with session-day nerves if not anticipated. We coordinate session timing around dose-escalation windows when nausea is highest, and we'll pre-medicate with ondansetron for patients prone to motion-sensitive nausea.
Frequently Asked Questions
I take Wegovy and feel nauseous a lot. Will ketamine make it worse?
Possibly mildly. We pre-medicate with ondansetron and time sessions for windows when your GLP-1 nausea is at its lowest — usually 3-5 days after a weekly injection rather than the day-of or day-after. Most patients tolerate the combination well once the timing is right.
I've heard Ozempic causes depression — will ketamine make it worse, or does it cancel out?
The FDA's January 2026 review of 91 trials (107,910 participants) found no causal link between GLP-1 drugs and depression at the population level. Ozempic itself never carried a suicidal-ideation warning — only the weight-loss-indicated GLP-1s did, and the FDA has now requested those be removed. Ketamine works through entirely separate pathways. If you've experienced mood changes on Ozempic personally, tell us — we plan sessions accordingly. See our full write-up on this.
Does Rybelsus (oral semaglutide) matter differently than Ozempic for KAP?
Same molecule, just oral. Rybelsus requires 30 minutes of fasting before swallowing, which fits cleanly with our pre-session fasting window. No additional planning needed beyond what's already required for KAP.
Should I tell you if my Wegovy or Ozempic dose was increased recently?
Yes — nausea typically spikes for 7-14 days after a dose escalation. We may delay the first session of a new ketamine cycle until you've stabilized on the new dose.
Can I do KAP if I've been on Ozempic for over a year?
Yes — long-term GLP-1 use doesn't change the ketamine interaction profile. Your tolerance to GI side effects is usually higher by that point, which actually makes session planning more straightforward.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Ozempic (Semaglutide) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications. Voelker R.. JAMA. 2026. PMID: 41615669
January 2026 FDA action removing the SI/B warning from Saxenda, Wegovy, and Zepbound after meta-analysis of 91 trials (107,910 participants) found no causal link to suicidality.
- Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder: A Randomized Clinical Trial. Husain MI, et al.. JAMA Psychiatry. 2026. PMID: 42054055
RCT showing semaglutide may improve effort-based decision-making in MDD independent of weight loss — early mechanistic signal supporting safe co-treatment with ketamine.
- Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs. et al.. International Journal of Clinical Pharmacy. 2026. PMID: 41739406
Pharmacovigilance analysis comparing suicidality-related AE reporting between GLP-1 RAs and non-GLP-1 anti-obesity drugs — no class-wide signal.
- GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide). Manoharan SVRR, et al.. Innovations in Clinical Neuroscience. 2024. PMID: 38938530
Case report of worsened depression on semaglutide. Relevant for intake screening even though the population-level data does not show a causal class effect.
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI.. Clinical Pharmacokinetics. 2016. PMID: 27028535
Comprehensive ketamine PK/PD review including CYP3A4 and CYP2B6 metabolism — establishes that GLP-1 RAs do not share these pathways.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 27, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.